Researchers and Clinicians
Reference card for physicians treating patients with A-T
This trial will evaluate the effects of EryDex in patients with A-T.
A-T mouse models are available from specific institutions and researchers.
A free resource for biomedical and life sciences literature.
A Letter of Intent is required prior to submission of a full-length proposal.
If invited to complete a full proposal, applicants must submit the form as a PDF to grants@atcp.org.
This trial in the Netherlands looked at the effects of nicotinamide ribose as a potential treatment for people with A-T.
Participants with A-T demonstrated lower brain activity or metabolism in the cerebellum as compared to control participants.
At the dose tested, Baclofen did not have a significant effect on tremor, eye movement or balance deficits.
This open label study was performed to assess the safety and tolerability of the EryDex System in people with A-T.